Securing FDA marketing authorization is a critical step for healthcare and biotech companies, often leading to increased investor confidence and potential market expansion. For Akili, a positive outcome would validate its EndeavorOTC product's efficacy and market viability, likely leading to a positive short-term impact on its stock price.